My top three takeaways from the 2020 San Antonio Breast Cancer Symposium.
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
Possible health policy changes in the coming months could be critical for anyone affected by or potentially affected by cancer.
Stand Up To Cancer funds cancer research “Dream Teams” with a common goal of moving new cancer therapies quickly from the lab to patients.
A major new report details action needed to accelerate progress against metastatic breast cancer so that it can be treated as a manageable condition with good quality of life.